Skip to main content

Posts

Infanticide and its Legal Status

Infanticide Infanticide is child murder in the first year of life. We define maternal filicide as a child murder by the mother.  Neonaticide is the murder of an infant within the first 24 hours of life. Almost all neonaticides are committed by mothers. Neonaticidal mothers are often young, unmarried women with unwanted pregnancies who receive no prenatal care. Infanticide laws often reduce the penalty for mothers who kill their children up to one year of age, based on the principle that a woman who commits infanticide does so because " the balance of her mind is disturbed because of her not having fully recovered from the effect of giving birth to the child" . The infanticide law allows mothers to be charged with manslaughter rather than murder if they are suffering from a mental disturbance. However, women convicted of infanticide sometimes do not have significant mental illness as technically required by the law (so e.g. as per the definition of mental disorder under Pun

ICD-11 Criteria for Disorders due to the Use of Non-psychoactive Substances (6C4H)

ICD-11 Criteria for Disorders due to the Use of Non-Psychoactive Substances (6C4H) Disorders due to use of non-psychoactive substances are characterised by the pattern and consequences of non-medical use of non-psychoactive substances. Non-psychoactive substances include laxatives, growth hormone, erythropoietin, and non-steroidal anti-inflammatory drugs. They may also include proprietary or over-the-counter medicines and folk remedies. Non-medical use of these substances may be associated with harm to the individual because of the direct or secondary toxic effects of the non-psychoactive substance on body organs and systems, or a harmful route of administration (e.g., infections due to intravenous self-administration). They are not associated with intoxication or with a dependence or withdrawal syndrome and are not recognized causes of substance-induced mental disorders. 6C4H.0            Episode of harmful use of non-psychoactive substances An episode of use of a non-psychoactive

ICD-11 Criteria for Generalised Anxiety Disorder (GAD)

ICD-11 Criteria for Generalised Anxiety Disorder (GAD) Foundation URI:   http://id.who.int/icd/entity/1712535455 Description Generalised anxiety disorder is characterised by marked symptoms of anxiety that persist for at least several months, for more days than not, manifested by either general apprehension (i.e. ‘free-floating anxiety’) or excessive worry focused on multiple everyday events, most often concerning family, health, finances, and school or work, together with additional symptoms such as muscular tension or motor restlessness, sympathetic autonomic over-activity, subjective experience of nervousness, difficulty maintaining concentration, irritability, or sleep disturbance. The symptoms result in significant distress or significant impairment in personal, family, social, educational, occupational, or other important areas of functioning. The symptoms are not a manifestation of another health condition and are not due to the effects of a substance or medication on the centra

ICD-11 Criteria for Secondary Impulse Control Syndrome (6E66)

ICD-11 Criteria for Secondary Impulse Control Syndrome (6E66) A syndrome characterised by the presence of prominent symptoms that are characteristic of Impulse Control Disorders or Disorders Due to Addictive Behaviours (e.g., stealing, fire-setting, aggressive outbursts, compulsive sexual behaviour, excessive gambling) that are judged to be a direct pathophysiological consequence of a health condition not classified under mental and behavioural disorders, based on evidence from the history, physical examination, or laboratory findings. The symptoms are not accounted for by delirium or by another mental and behavioural disorder, and are not a psychologically mediated response to a severe medical condition (e.g., as part of an adjustment disorder in response to a life-threatening diagnosis). This category should be used in addition to the diagnosis for the presumed underlying disorder or disease when the impulse control symptoms are sufficiently severe to warrant specific clinical attent

ICD-11 Criteria for Secondary Neurocognitive Syndrome (6E67)

ICD-11 Criteria for Secondary Neurocognitive Syndrome (6E67) A syndrome that involves significant cognitive features that do not fulfill the diagnostic requirements of any of the specific neurocognitive disorders and are judged to be a direct pathophysiological consequence of a health condition or injury not classified under mental and behavioural disorders (e.g., cognitive changes due to a brain tumour), based on evidence from the history, physical examination, or laboratory findings. This category should be used in addition to the diagnosis for the presumed underlying disorder or disease when the cognitive symptoms are sufficiently severe to warrant specific clinical attention. Coding Note :       Code also the causing condition Exclusions: Disorders with neurocognitive impairment as a major feature (BlockL1‑8A2) Coded Elsewhere:    Delirium (6D70) REFERENCE: International Classification of Diseases Eleventh Revision (ICD-11). Geneva: World Health Organization; 2022. License: